Skip to main content
Contact Us
Subscribe
E-Edition
75°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about PTGX
Recent news which mentions PTGX
< Previous
1
2
3
4
Next >
Why Protagonist Therapeutics Shares Are Crashing Today
April 26, 2022
Tickers
PTGX
Tags
Benzinga
General
why it's moving
From
Benzinga
The Daily Biotech Pulse: Protagonist's Ulcerative Colitis Study Disappoints, Gilead's Remdesivir Approved For Pediatric COVID-19 Patients, FDA Gives Nod To Gamida's Cell Therapy Trial, Fast Track Tag
April 26, 2022
Tickers
AGRX
AMAM
BGNE
GILD
Tags
Penny Stocks
VALN
Health Care
From
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 26, 2022
Tickers
AGRX
AVDL
BBLG
ERYP
Tags
ETTX
TCRT
BBLG
From
Benzinga
18 Stocks Moving in Tuesday's Pre-Market Session
April 26, 2022
Tickers
AGRX
AIM
ALZN
AVDL
Tags
Top Gainers
HSBC
MGTA
From
Benzinga
Protagonist Therapeutics Topline Data from Phase 2 IDEAL Study of PN-943 (450 mg BID) Miss Primary Endpoint
April 25, 2022
Tickers
PTGX
Tags
Benzinga
Health Care
News
From
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 20, 2022
Tickers
BSGM
CLSN
ENDP
KTRA
Tags
CLSN
OCX
BZI/TFM
From
Benzinga
51 Biggest Movers From Thursday
April 18, 2022
Tickers
AIRG
AMST
APCX
AREB
Tags
Small Cap
VSTM
ARTL
From
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 14, 2022
Tickers
BFRI
CLRB
HSTO
ISO
Tags
VSTM
Market News
Movers
From
Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More
April 14, 2022
Tickers
ABBV
AMRX
BNTX
BYSI
Tags
IVBXF
Health Care
VALN
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 14, 2022
Tickers
AGRX
AIM
AIRG
APLD
Tags
DLPN
CRXT
BFRI
From
InvestorPlace
FDA Intends To Revoke Protagonist Therapeutics' Rusfertide Breakthrough Tag In Rare Form Of Blood Cancer
April 14, 2022
Tickers
PTGX
Tags
Biotech
FDA
Benzinga
From
Benzinga
Protagonist Therapeutics Earns $25M Milestone Payment From Janssen Biotech
March 16, 2022
Tickers
JNJ
PTGX
Tags
Contracts
Benzinga
General
From
Benzinga
Protagonist Therapeutics's Return On Capital Employed Overview
March 03, 2022
Tickers
PTGX
Tags
PTGX
Benzinga
BZI/ROCE
From
Benzinga
3 Desirable Drug Stocks With Very Promising Pipelines
February 16, 2022
Tickers
AGIO
BMY
HRMY
JNJ
Tags
XBI
BMY
SDGR
From
InvestorPlace
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
Tickers
ABBV
ADCT
AGIO
ALNY
Tags
APRE
Penny Stocks
FMTX
From
Benzinga
Protagonist To Go Ahead With Oral Peptide PN-235, Discontinues Phase 1 Candidate
December 03, 2021
Tickers
JNJ
PTGX
Tags
Trading Ideas
News
Health Care
From
Benzinga
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
December 03, 2021
Tickers
BGNE
BMY
ESPR
IBB
Tags
General
ESPR
Benzinga
From
Benzinga
What 9 Analyst Ratings Have To Say About Protagonist Therapeutics
November 15, 2021
Tickers
PTGX
Tags
Benzinga
PTGX
BZI/AAR
From
Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Tickers
ABUS
ACAD
ACIU
ADAP
Tags
AZN
VBIV
CCXI
From
Benzinga
Why Protagonist Therapeutics Stock Skyrocketed 80.2% Last Month
November 08, 2021
Tickers
PTGX
Tags
Market News
PTGX
Recent Press Releases
From
Motley Fool
5 Short Squeeze Candidates To Watch: Progenity Tops List Again, Augmented Reality Play WiMi Hologram Joins List
November 01, 2021
Tickers
AMC
ASLE
BTBT
GLG
Tags
Penny Stocks
PTGX
WIMI
From
Benzinga
Short Squeeze Stocks: PTGX, AGC and 3 Others Experts Think Are Ready to Pop
October 25, 2021
Tickers
AGC
DBGI
PALT
PROG
Tags
Market News
DBGI
NASDAQ:PROG,NASDAQ:DBGI,NASDAQ:PTGX,NASDAQ:AGC,NASDAQ:PALT
From
InvestorPlace
5 Short Squeeze Candidates To Watch: Progenity, Digital Brands Top List Again, SPAC AGC Joins Ahead Of Merger
October 25, 2021
Tickers
AGC
AMC
DBGI
GME
Tags
PALT
Benzinga
Stocks To Watch
From
Benzinga
The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs
October 22, 2021
Tickers
ADPT
ATHA
AVRO
IBB
Tags
ME
FDA
Biotech
From
Benzinga
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
October 18, 2021
Tickers
ABEO
ABT
AVDL
AVRO
Tags
HLTH
General
ISRG
From
Benzinga
Ten stocks worth watching next week
October 16, 2021
Tickers
AA
ADMP
FCEL
MFH
Tags
FCEL
AA
PTGX
From
AC Investor Blog
What 10 Analyst Ratings Have To Say About Protagonist Therapeutics
October 13, 2021
Tickers
PTGX
Tags
PTGX
Benzinga
Analyst Ratings
From
Benzinga
10 Biggest Price Target Changes For Wednesday
October 13, 2021
Tickers
CLR
GPK
HUBS
PTGX
Tags
Market News
SGH
PTGX
From
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 12, 2021
Tickers
ENZ
ICVX
IKNA
INBX
Tags
Benzinga
TRVI
BZI/TFM
From
Benzinga
Analyst Ratings For Protagonist Therapeutics
October 12, 2021
Tickers
PTGX
Tags
Benzinga
PTGX
BZI/AAR
From
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.